Fernando Korn Malerbi

Dr. Fernando Korn Malerbi

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
PDF file
FMFernando Korn Malerbi
Fernando Korn Malerbi
RARafael Ernane Andrade
Rafael Ernane Andrade
PMPaulo Henrique Morales
Paulo Henrique Morales
JSJosé Augusto Stuchi
José Augusto Stuchi
DLDiego Lencione
Diego Lencione
RBRubens Belfort
Rubens Belfort
Background: Portable retinal cameras and deep learning (DL) algorithms are novel tools adopted by diabetic retinopathy (DR) screening programs. Our objective is to evaluate the diagnostic accuracy of a DL algorithm and the performance of portable handheld retinal cameras in the detection of DR in a large and heterogenous type 2 diabetes population in a real-world, high burden setting. Method: Participants underwent fundus photographs of both eyes with a portable retinal camera (Phelcom Eyer). Classification of DR was performed by human reading and a DL algorithm (PhelcomNet), consisting of a convolutional neural network trained on a dataset of fundus images captured exclusively with the portable device; both methods were compared. We calculated the area under the curve (AUC), sensitivity, and specificity for more than mild DR. Results: A total of 824 individuals with type 2 diabetes were enrolled at Itabuna Diabetes Campaign, a subset of 679 (82.4%) of whom could be fully assessed. The algorithm sensitivity/specificity was 97.8 % (95% CI 96.7-98.9)/61.4 % (95% CI 57.7-65.1); AUC was 0·89. All false negative cases were classified as moderate non-proliferative diabetic retinopathy (NPDR) by human grading. Conclusions: The DL algorithm reached a good diagnostic accuracy for more than mild DR in a real-world, high burden setting. The performance of the handheld portable retinal camera was adequate, with over 80% of individuals presenting with images of sufficient quality. Portable devices and artificial intelligence tools may increase coverage of DR screening programs.

22 June 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
FMFernando Korn Malerbi
Fernando Korn Malerbi
LNLuis Filipe Nakayama
Luis Filipe Nakayama
RDRobyn Gayle Dychiao
Robyn Gayle Dychiao
Lucas Zago RibeiroLucas Zago Ribeiro
Lucas Zago Ribeiro
CVCleva Villanueva
Cleva Villanueva
CRCaio Vinicius Regatieri
Caio Vinicius Regatieri
Artificial Intelligence (AI) represents a significant milestone in health care's digital transformation. However, traditional health care education and training often lack digital competencies. To promote safe and effective AI implementation, health care professionals must acquire basic knowledge of machine learning and neural networks, critical evaluation of data sets, integration within clinical workflows, bias control, and human-machine interaction in clinical settings. Additionally, they should understand the legal and ethical aspects of digital health care and the impact of AI adoption. Misconceptions and fears about AI systems could jeopardize its real-life implementation. However, there are multiple barriers to promoting electronic health literacy, including time constraints, overburdened curricula, and the shortage of capacitated professionals. To overcome these challenges, partnerships among developers, professional societies, and academia are essential. Integrating specialists from different backgrounds, including data specialists, lawyers, and social scientists, can significantly contribute to combating digital illiteracy and promoting safe AI implementation in health care.

21 September 2023 in Annals of Medicine
Verified
Journal Article
Open access
LNLuis Filipe Nakayama
Luis Filipe Nakayama
Lucas Zago RibeiroLucas Zago Ribeiro
Lucas Zago Ribeiro
FNFrederico Novaes
Frederico Novaes
IMIsabele Ayumi Miyawaki
Isabele Ayumi Miyawaki
AMAndresa Emy Miyawaki
Andresa Emy Miyawaki
PSPaolo S. Silva
Paolo S. Silva
This study aims to compare artificial intelligence (AI) systems applied in diabetic retinopathy (DR) teleophthalmology screening, currently deployed systems, fairness initiatives and the challenges for implementation. The review included articles retrieved from PubMed/Medline/EMBASE literature search strategy regarding telemedicine, DR and AI. The screening criteria included human articles in English, Portuguese or Spanish and related to telemedicine and AI for DR screening. The author’s affiliations and the study’s population income group were classified according to the World Bank Country and Lending Groups. The literature search yielded a total of 132 articles, and nine were included after full-text assessment. The selected articles were published between 2004 and 2020 and were grouped as telemedicine systems, algorithms, economic analysis and image quality assessment. Four telemedicine systems that perform a quality assessment, image preprocessing and pathological screening were reviewed. A data and post-deployment bias assessment are not performed in any of the algorithms, and none of the studies evaluate the social impact implementations. There is a lack of representativeness in the reviewed articles, with most authors and target populations from high-income countries and no low-income country representation. Telemedicine and AI hold great promise for augmenting decision-making in medical care, expanding patient access and enhancing cost-effectiveness. Economic studies and social science analysis are crucial to support the implementation of AI in teleophthalmology screening programs. Promoting fairness and generalizability in automated systems combined with telemedicine screening programs is not straightforward. Improving data representativeness, reducing biases and promoting equity in deployment and post-deployment studies are all critical steps in model development.

30 October 2019 in PeerJ
Verified
Journal Article
Open access
PDF file
CBChristophe Boudry
Christophe Boudry
PAPatricio Alvarez-Muñoz
Patricio Alvarez-Muñoz
RARicardo Arencibia-Jorge
Ricardo Arencibia-Jorge
DADidier Ayena
Didier Ayena
NBNiels Brouwer
Niels Brouwer
FMFrederic Mouriaux
Frederic Mouriaux
Background: The problem of access to medical information, particularly in low-income countries, has been under discussion for many years. Although a number of developments have occurred in the last decade (e.g., the open access (OA) movement and the website Sci-Hub), everyone agrees that these difficulties still persist very widely, mainly due to the fact that paywalls still limit access to approximately 75% of scholarly documents. In this study, we compare the accessibility of recent full text articles in the field of ophthalmology in 27 established institutions located worldwide. Methods: A total of 200 references from articles were retrieved using the PubMed database. Each article was individually checked for OA. Full texts of non-OA (i.e., “paywalled articles”) were examined to determine whether they were available using institutional and Hinari access in each institution studied, using “alternative ways” (i.e., PubMed Central, ResearchGate, Google Scholar, and Online Reprint Request), and using the website Sci-Hub. Results: The number of full texts of “paywalled articles” available using institutional and Hinari access showed strong heterogeneity, scattered between 0% full texts to 94.8% (mean = 46.8%; SD = 31.5; median = 51.3%). We found that complementary use of “alternative ways” and Sci-Hub leads to 95.5% of full text “paywalled articles,” and also divides by 14 the average extra costs needed to obtain all full texts on publishers’ websites using pay-per-view. Conclusions: The scant number of available full text “paywalled articles” in most institutions studied encourages researchers in the field of ophthalmology to use Sci-Hub to search for scientific information. The scientific community and decision-makers must unite and strengthen their efforts to find solutions to improve access to scientific literature worldwide and avoid an implosion of the scientific publishing model. This study is not an endorsement for using Sci-Hub. The authors, their institutions, and publishers accept no responsibility on behalf of readers.

4 August 2020 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
MQMárcia Silva Queiroz
Márcia Silva Queiroz
JCJacira Xavier de Carvalho
Jacira Xavier de Carvalho
SBSilvia Ferreira Bortoto
Silvia Ferreira Bortoto
MMMozania Reis de Matos
Mozania Reis de Matos
CCCristiane das Graças Dias Cavalcante
Cristiane das Graças Dias Cavalcante
FMFernando Korn Malerbi
Fernando Korn Malerbi

11 July 2024 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
LNLuis Filipe Nakayama
Luis Filipe Nakayama
DRDavid Restrepo
David Restrepo
João MatosJoão Matos
João Matos
Lucas Zago RibeiroLucas Zago Ribeiro
Lucas Zago Ribeiro
FMFernando Korn Malerbi
Fernando Korn Malerbi
CRCaio Vinicius Regatieri
Caio Vinicius Regatieri
Introduction: The Brazilian Multilabel Ophthalmological Dataset (BRSET) addresses the scarcity of publicly available ophthalmological datasets in Latin America. BRSET comprises 16,266 color fundus retinal photos from 8,524 Brazilian patients, aiming to enhance data representativeness, serving as a research and teaching tool. It contains sociodemographic information, enabling investigations into differential model performance across demographic groups. Methods: Data from three São Paulo outpatient centers yielded demographic and medical information from electronic records, including nationality, age, sex, clinical history, insulin use, and duration of diabetes diagnosis. A retinal specialist labeled images for anatomical features (optic disc, blood vessels, macula), quality control (focus, illumination, image field, artifacts), and pathologies (e.g., diabetic retinopathy). Diabetic retinopathy was graded using International Clinic Diabetic Retinopathy and Scottish Diabetic Retinopathy Grading. Validation used a ConvNext model trained during 50 epochs using a weighted cross entropy loss to avoid overfitting, with 70% training (20% validation), and 30% testing subsets. Performance metrics included area under the receiver operating curve (AUC) and Macro F1-score. Saliency maps were calculated for interpretability. Results: BRSET comprises 65.1% Canon CR2 and 34.9% Nikon NF5050 images. 61.8% of the patients are female, and the average age is 57.6 (± 18.26) years. Diabetic retinopathy affected 15.8% of patients, across a spectrum of disease severity. Anatomically, 20.2% showed abnormal optic discs, 4.9% abnormal blood vessels, and 28.8% abnormal macula. A ConvNext V2 model was trained and evaluated BRSET in four prediction tasks: “binary diabetic retinopathy diagnosis (Normal vs Diabetic Retinopathy)” (AUC: 97, F1: 89); “3 class diabetic retinopathy diagnosis (Normal, Proliferative, Non-Proliferative)” (AUC: 97, F1: 82); “diabetes diagnosis” (AUC: 91, F1: 83); “sex classification” (AUC: 87, F1: 70). Discussion: BRSET is the first multilabel ophthalmological dataset in Brazil and Latin America. It provides an opportunity for investigating model biases by evaluating performance across demographic groups. The model performance of three prediction tasks demonstrates the value of the dataset for external validation and for teaching medical computer vision to learners in Latin America using locally relevant data sources.